See more : Dexco S.A. (DXCO3.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Trulieve Cannabis Corp. (TCNNF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trulieve Cannabis Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- OneSoft Solutions Inc. (OSS.V) Income Statement Analysis – Financial Results
- PTC India Financial Services Limited (PFS.BO) Income Statement Analysis – Financial Results
- Mukand Limited (MUKANDLTD.NS) Income Statement Analysis – Financial Results
- PT Cilacap Samudera Fishing Industry Tbk (ASHA.JK) Income Statement Analysis – Financial Results
- Spineway SA (ALSPW.PA) Income Statement Analysis – Financial Results
Trulieve Cannabis Corp. (TCNNF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.trulieve.com
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13B | 1.24B | 938.39M | 521.53M | 252.82M | 102.82M | 19.78M | 161.15K |
| Cost of Revenue | 540.57M | 557.80M | 372.26M | 135.12M | -109.47M | -2.75M | 1.36M | 2.81M |
| Gross Profit | 588.63M | 682.00M | 566.13M | 386.42M | 362.28M | 105.56M | 18.42M | -2.65M |
| Gross Profit Ratio | 52.13% | 55.01% | 60.33% | 74.09% | 143.30% | 102.67% | 93.14% | -1,642.14% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 146.00M | 169.70M | 100.57M | 36.06M | 14.07M | 4.14M | 35.79K | 35.65K |
| Selling & Marketing | 240.17M | 284.90M | 215.14M | 119.40M | 53.94M | 25.05M | 7.10M | 235.26K |
| SG&A | 386.16M | 454.60M | 315.72M | 155.45M | 68.01M | 29.19M | 35.79K | 35.65K |
| Other Expenses | 424.08M | 119.40M | 48.10M | 12.60M | 8.40M | 1.14M | -32.60 | 41.45K |
| Operating Expenses | 810.24M | 574.00M | 363.81M | 168.05M | 76.40M | 30.32M | 35.76K | 77.10K |
| Cost & Expenses | 1.35B | 1.13B | 736.07M | 303.17M | -33.06M | 27.58M | 35.76K | 77.10K |
| Interest Income | 6.16M | 78.47M | 34.59M | 20.24M | 9.05M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.57M | 79.80M | 34.79M | 20.24M | 12.82M | 2.18M | 0.00 | 0.00 |
| Depreciation & Amortization | 169.91M | 185.57M | 78.22M | 30.19M | 17.19M | 3.11M | 558.01K | 113.20K |
| EBITDA | -36.78M | 239.75M | 283.59M | 207.87M | 128.54M | 38.25M | 10.47M | -4.00M |
| EBITDA Ratio | -3.26% | 18.45% | 30.02% | 39.86% | 119.64% | 74.91% | -0.18% | -4.55% |
| Operating Income | -221.61M | 109.40M | 196.95M | 218.37M | 285.88M | 75.24M | -35.76K | -77.10K |
| Operating Income Ratio | -19.63% | 8.82% | 20.99% | 41.87% | 113.08% | 73.18% | -0.18% | -47.84% |
| Total Other Income/Expenses | -62.92M | -69.40M | -27.80M | -60.85M | -9.59M | -2.04M | -1.63M | -362.15K |
| Income Before Tax | -284.54M | -43.30M | 163.51M | 157.45M | 272.47M | 71.73M | -36.35K | -7.33K |
| Income Before Tax Ratio | -25.20% | -3.49% | 17.42% | 30.19% | 107.77% | 69.76% | -0.18% | -4.55% |
| Income Tax Expense | 151.36M | 161.80M | 146.06M | 94.45M | 94.44M | 28.76M | 4.72M | 0.00 |
| Net Income | -526.80M | -205.10M | 18.03M | 63.00M | 178.03M | 42.97M | -36.35K | -7.33K |
| Net Income Ratio | -46.65% | -16.54% | 1.92% | 12.08% | 70.42% | 41.79% | -0.18% | -4.55% |
| EPS | -2.84 | -1.10 | 0.13 | 0.55 | 1.62 | 0.42 | 0.00 | 0.00 |
| EPS Diluted | -2.84 | -1.09 | 0.12 | 0.53 | 1.54 | 0.42 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 188.97M | 187.27M | 142.65M | 113.57M | 110.21M | 101.70M | 109.81M | 109.81M |
| Weighted Avg Shares Out (Dil) | 188.97M | 188.00M | 146.76M | 118.33M | 115.32M | 103.20M | 109.81M | 109.81M |
Trulieve's Growth Trajectory: Q1 Success, Florida Legalization Hopes, And DEA Rescheduling Impact
3 Marijuana Stock For Your 2024 Watch List This Month
Trulieve CEO Kim Rivers welcomes Biden administration's move to reschedule cannabis
Looking For The Bud Light Of Cannabis
Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for May 2024
3 Cheap Cannabis Stocks to Buy Now: May 2024
3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings
Top Marijuana Stocks For Cannabis Investing In May
Trulieve to Open Medical Cannabis Dispensary in Stuart, Florida
Trulieve Cannabis Corp. (TCNNF) Q1 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports